Form 4: OraSure Director Covers Taxes With 7,317 Shares, Holds 99k

Rhea-AI Filing Summary

OraSure Technologies (OSUR) – Form 4 filing, 07/31/2025: Director Robert W. McMahon satisfied tax withholding on recently vested restricted stock by having 7,317 common shares withheld by the company at an implied price of $3.205 per share (Transaction Code F). Following the transaction, McMahon continues to hold 99,919 shares directly. No derivative securities were reported.

Code F denotes a non-open-market disposition strictly for tax obligations; therefore, it does not represent an active sale decision and has minimal signalling value. The remaining stake indicates continued alignment with shareholders. No other transactions, options, or changes in beneficial ownership were disclosed.

Insights

Securities Analyst

TL;DR: Routine tax-withholding; negligible impact on OSUR valuation.

Code F filings are generally non-informative because shares are withheld automatically to cover statutory taxes on vesting restricted stock units. The 7,317 shares equal roughly 6.8% of McMahon’s post-transaction holdings and a <1% fraction of OSUR’s float—far below any threshold that might influence supply-demand dynamics. The director’s residual 99,919-share position signals sustained exposure to company performance. No derivatives or open-market activity were reported, leaving insider sentiment unchanged. From a governance and liquidity standpoint, this event is not impactful for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McMahon Robert W.

(Last) (First) (Middle)

C/O ORASURE TECHNOLOGIES INC

220 EAST FIRST STREET

(Street)

BETHLEHEM PA 18015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2025		F(1)		7,317	D	$3.205	99,919	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares to pay the tax liability associated with vesting of restricted shares.

	/s/ Michele Anthony, Attorney-in-Fact	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OSUR Director Robert W. McMahon report in the latest Form 4?

He had 7,317 shares withheld on 07/31/2025 to pay taxes on vested restricted stock and now owns 99,919 shares.

Does the transaction represent an open-market sale of OraSure shares?

No. Transaction Code F indicates shares were withheld by the issuer solely for tax withholding, not a discretionary sale.

How many OraSure shares does McMahon hold after the transaction?

The director’s direct ownership stands at 99,919 common shares following the tax-withholding event.

Is this Form 4 filing likely to impact OSUR stock price?

Given the small size and routine nature of tax withholding, the filing is generally considered immaterial to market dynamics.

Were any derivative securities such as options disclosed in this Form 4?

No derivative securities were reported; only common stock was listed in Table I.